These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 12709399)

  • 1. Advanced glycation end products activate Smad signaling via TGF-beta-dependent and independent mechanisms: implications for diabetic renal and vascular disease.
    Li JH; Huang XR; Zhu HJ; Oldfield M; Cooper M; Truong LD; Johnson RJ; Lan HY
    FASEB J; 2004 Jan; 18(1):176-8. PubMed ID: 12709399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-beta and Smad signalling in kidney diseases.
    Wang W; Koka V; Lan HY
    Nephrology (Carlton); 2005 Feb; 10(1):48-56. PubMed ID: 15705182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
    Lan HY
    Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AGEs activate mesangial TGF-beta-Smad signaling via an angiotensin II type I receptor interaction.
    Fukami K; Ueda S; Yamagishi S; Kato S; Inagaki Y; Takeuchi M; Motomiya Y; Bucala R; Iida S; Tamaki K; Imaizumi T; Cooper ME; Okuda S
    Kidney Int; 2004 Dec; 66(6):2137-47. PubMed ID: 15569303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAGE- and TGF-beta receptor-mediated signals converge on STAT5 and p21waf to control cell-cycle progression of mesangial cells: a possible role in the development and progression of diabetic nephropathy.
    Brizzi MF; Dentelli P; Rosso A; Calvi C; Gambino R; Cassader M; Salvidio G; Deferrari G; Camussi G; Pegoraro L; Pagano G; Cavallo-Perin P
    FASEB J; 2004 Aug; 18(11):1249-51. PubMed ID: 15180953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
    Kim HS; Luo L; Pflugfelder SC; Li DQ
    Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):840-8. PubMed ID: 15728539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of transforming growth factor beta(1)/Smad signalling mediated by mitogen-activated protein kinase pathways in keloid fibroblasts.
    He S; Liu X; Yang Y; Huang W; Xu S; Yang S; Zhang X; Roberts MS
    Br J Dermatol; 2010 Mar; 162(3):538-46. PubMed ID: 19772524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of TGF-beta signaling in extracellular matrix production under high glucose conditions.
    Li JH; Huang XR; Zhu HJ; Johnson R; Lan HY
    Kidney Int; 2003 Jun; 63(6):2010-9. PubMed ID: 12753288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
    Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites.
    Tardif G; Reboul P; Dupuis M; Geng C; Duval N; Pelletier JP; Martel-Pelletier J
    J Rheumatol; 2001 Jul; 28(7):1631-9. PubMed ID: 11469472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smad2 mediates Erk1/2 activation by TGF-beta1 in suspended, but not in adherent, gastric carcinoma cells.
    Lee MS; Ko SG; Kim HP; Kim YB; Lee SY; Kim SG; Jong HS; Kim TY; Lee JW; Bang YJ
    Int J Oncol; 2004 May; 24(5):1229-34. PubMed ID: 15067346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
    Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
    Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis.
    Javelaud D; Mauviel A
    Oncogene; 2005 Aug; 24(37):5742-50. PubMed ID: 16123807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
    Chung AC; Zhang H; Kong YZ; Tan JJ; Huang XR; Kopp JB; Lan HY
    J Am Soc Nephrol; 2010 Feb; 21(2):249-60. PubMed ID: 19959709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smad expression in human atherosclerotic lesions: evidence for impaired TGF-beta/Smad signaling in smooth muscle cells of fibrofatty lesions.
    Kalinina N; Agrotis A; Antropova Y; Ilyinskaya O; Smirnov V; Tararak E; Bobik A
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1391-6. PubMed ID: 15166010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells.
    Hayashida T; Decaestecker M; Schnaper HW
    FASEB J; 2003 Aug; 17(11):1576-8. PubMed ID: 12824291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory smads and tgf-Beta signaling in glomerular cells.
    Schiffer M; Schiffer LE; Gupta A; Shaw AS; Roberts IS; Mundel P; Böttinger EP
    J Am Soc Nephrol; 2002 Nov; 13(11):2657-66. PubMed ID: 12397035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced-glycation-end-product-cholesterol-aggregated-protein accelerates the proliferation of mesangial cells mediated by transforming-growth-factor-beta 1 receptors and the ERK-MAPK pathway.
    Hirasawa Y; Sakai T; Ito M; Yoshimura H; Feng Y; Nagamatsu T
    Eur J Pharmacol; 2011 Dec; 672(1-3):159-68. PubMed ID: 21989075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.